Discover why VigRX Organic Bio Maca is being recognized in 2025 as the best maca root supplement for men and women. Explore ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare ...

Nugevia GLO leverages the potent synergy of JOTROL™, Jupiter's clinically validated resveratrol delivery technology, and NovaSOL® Astaxanthin, a powerful antioxidant known for its skin-enhancing ...

New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg ...

Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, ...

The Company expects to submit an Investigational Device Exemption (IDE) and commence U.S. clinical trials in 2025 to support a labeling indication to commercialize the Autonomix Sensing and RF ...

In 2025, Happy Go Leafy has expanded its offerings with new Kratom strains designed to meet the evolving needs of consumers. These strains are crafted to provide a wide range of benefits, from pain ...

Alcohol Use Disorder affects over 280 million people globally, representing a significant unmet medical need and a potential multibillion-dollar market opportunity. Despite its prevalence, current ...

The securities described above are being offered by CorMedix pursuant to a shelf registration statement on Form S-3 which was initially filed by CorMedix with the Securities and Exchange Commission ...

NOVATO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that it has received Breakthrough Therapy Designation from the U.S. Food and Drug ...

The Company’s common stock will continue to trade on The Nasdaq Capital Market under the symbol “HSDT.” The new CUSIP number for the common stock following the reverse split is 42328V 876.

RedTail represents the culmination of over a decade of meticulous research and innovation at Calidi to create what we believe is the most advanced systemic virotherapy platform. Advancing this novel ...